e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Quality of diagnosis and assessment in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metrics of salbutamol use as predictors of future adverse outcomes in asthma
M. Weatherall, M. Patel, J. Pilcher, H. Reddel, D. Shaw, R. Beasley (Wellington, New Zealand; Nottingham, United Kingdom; Sydney, Australia)
Source:
Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Session:
Quality of diagnosis and assessment in primary care
Session type:
Poster Discussion
Number:
278
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Weatherall, M. Patel, J. Pilcher, H. Reddel, D. Shaw, R. Beasley (Wellington, New Zealand; Nottingham, United Kingdom; Sydney, Australia). Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Eur Respir J 2013; 42: Suppl. 57, 278
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Predictors of exacerbations in asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Oral corticosteroids in asthma exacerbations: Differences between patient-reported data and proxies from claims data
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Risk for adverse outcomes in asthma: Assess to impress!
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Assessing asthma risk in primary care: Can the AAA test predict future asthma attacks?
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Factors related with hospitalizations due to asthma exacerbations
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Identifying patients at risk for future exacerbations of asthma: Development of a prediction model
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Barriers to adherence to asthma medication
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence?
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Prognostic factors of mortality and cardiovascular outcomes in the tiotropium safety and performance in respimat (TIOSPIR) trial
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Real-life asthma impairment: SABA use depends on smoking phenotype
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept